Vitalchat
Vitalchat easily integrates into existing workflows and technologies, monitors patients across any configuration, leverages video to proactively monitor for falls, pressure ulcers, and visitors, and allows the care team to speak or type a message and have it spoken or transcribed to the patient in a variety of languages, enabling families, clinicians and healthcare administrators improve patient safety that can be stood up in minutes.
$6M
Latest Funding
Series A
Latest Funding Stage
2025-02-13
Funding Date
$6M
Total Funding
19
Employees
United States
Location
Ashburn, Virginia
City & State
Sales-Ready Summary
With $6M in Series A funding secured in February 2025, Vitalchat is actively hiring for sales roles and leveraging technologies like React, AWS, and Microsoft 365, signaling a strong potential for sales and marketing tools to support their growth initiatives.
Key Contacts
Open Positions
View Careers PageHiring For
Similar Startups
Archipelo
The Archipelo Developer Security Posture Management Platform provides organizations with—the underlying system of record to capture SDLC event data tied to developer actions. Archipelo empowers security, GRC, and engineering teams to proactively identify, triage, and mitigate risks before they impact your business.
Workhelix
Workhelix brings together advanced research and comprehensive data to assess organizations' generative AI opportunities and which tasks can be accelerated with available technology, enabling businesses to navigate the opportunity landscape with data and reports, rather than relying on gut and instinct.
Subscript
Subscript is a platform that allows users to develop, understand, and manage subscription businesses. This enables members to update the database, calculate measures such as ARR, net revenue retention, CAC, LTV, ARPA, and so on, and analyze customer segments.
Eikon Therapeutics
Eikon Therapeutics is a biopharmaceutical company that focuses on developing innovative technologies for drug discovery. The company utilizes advanced live-cell resolution microscopy and engineering to identify and create new therapeutic candidates. Eikon Therapeutics aims to enhance the understanding of biological processes at a cellular level,supporting targeted treatment development.